Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumor-Reference-Cited by-同舟云学术

Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumor

Published:2020-10-09 Issue:10 Volume:15 Page:e0226464
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Chang Tiffany C.^ORCID,Matossian Margarite D.,Elliott Steven,Burks Hope E.,Sabol Rachel A.,Ucar Deniz A.,Wathieu Henri,Zabaleta Jovanny,Valle Luis De,Gill Sukhmani,Martin Elizabeth,Riker Adam I.,Miele Lucio,Bunnell Bruce A.,Burow Matthew E.,Collins-Burow Bridgette M.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference68 articles.

1. Clinicopathologic study of 53 metaplastic breast carcinomas: their elements and prognostic implications;R Yamaguchi;Human pathology,2010

2. Metaplastic breast cancer: to radiate or not to radiate?;WH Tseng;Annals of surgical oncology,2011

3. Basal-like and triple-negative breast cancers: searching for positives among many negatives;P Alluri;Surgical Oncology Clinics,2014

4. Survival outcomes of metaplastic breast cancer patients: results from a US population-based analysis;RA Nelson;Annals of surgical oncology,2015

5. Characteristics and treatment of metaplastic breast cancer: analysis of 892 cases from the National Cancer Data Base;CM Pezzi;Annals of Surgical Oncology,2007

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Xenohormetic Phytochemicals Inhibit Neovascularization in Microphysiological Models of Vasculogenesis and Tumor Angiogenesis;Advanced Biology;2024-06-04

2. Characterisation of new in vitro models and identification of potentially active drugs in angiosarcoma;Biomedicine & Pharmacotherapy;2024-04

3. Epithelial to mesenchymal transition (EMT) in metaplastic breast cancer and phyllodes breast tumors;Medical Oncology;2023-12-16

4. Breast cancer organoids derived from patients: A platform for tailored drug screening;Biochemical Pharmacology;2023-11

5. Sulindac sulfide as a non-immune suppressive γ-secretase modulator to target triple-negative breast cancer;Frontiers in Immunology;2023-10-13